CA2704499C - Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies - Google Patents
Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies Download PDFInfo
- Publication number
- CA2704499C CA2704499C CA2704499A CA2704499A CA2704499C CA 2704499 C CA2704499 C CA 2704499C CA 2704499 A CA2704499 A CA 2704499A CA 2704499 A CA2704499 A CA 2704499A CA 2704499 C CA2704499 C CA 2704499C
- Authority
- CA
- Canada
- Prior art keywords
- seq
- nos
- expression level
- antibody
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 145
- 238000011282 treatment Methods 0.000 title claims abstract description 110
- 208000003950 B-cell lymphoma Diseases 0.000 title claims abstract description 75
- 230000004043 responsiveness Effects 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 358
- 239000000523 sample Substances 0.000 claims description 268
- 230000014509 gene expression Effects 0.000 claims description 212
- 210000004027 cell Anatomy 0.000 claims description 165
- 239000003550 marker Substances 0.000 claims description 121
- 101150013553 CD40 gene Proteins 0.000 claims description 86
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 86
- 230000035945 sensitivity Effects 0.000 claims description 73
- 206010025323 Lymphomas Diseases 0.000 claims description 53
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 50
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 50
- 206010028980 Neoplasm Diseases 0.000 claims description 50
- 101001012021 Homo sapiens Mammalian ependymin-related protein 1 Proteins 0.000 claims description 48
- 101000854774 Homo sapiens Pantetheine hydrolase VNN2 Proteins 0.000 claims description 48
- 102100020748 Pantetheine hydrolase VNN2 Human genes 0.000 claims description 48
- 102100030031 Mammalian ependymin-related protein 1 Human genes 0.000 claims description 47
- 101710148333 Regulator of G-protein signaling 13 Proteins 0.000 claims description 45
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims description 43
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims description 43
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 40
- 102000004169 proteins and genes Human genes 0.000 claims description 36
- 101000933604 Homo sapiens Protein BTG2 Proteins 0.000 claims description 35
- 102100026034 Protein BTG2 Human genes 0.000 claims description 35
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 claims description 33
- 101001034844 Homo sapiens Interferon-induced transmembrane protein 1 Proteins 0.000 claims description 33
- 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 claims description 33
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 32
- 102100032912 CD44 antigen Human genes 0.000 claims description 31
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 claims description 31
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 31
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims description 31
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 claims description 29
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims description 29
- 102100029921 Dipeptidyl peptidase 1 Human genes 0.000 claims description 28
- 101000793922 Homo sapiens Dipeptidyl peptidase 1 Proteins 0.000 claims description 28
- 101000662009 Homo sapiens UDP-N-acetylglucosamine pyrophosphorylase Proteins 0.000 claims description 28
- 102100037921 UDP-N-acetylglucosamine pyrophosphorylase Human genes 0.000 claims description 28
- 101000590549 Homo sapiens Pseudouridylate synthase 7 homolog Proteins 0.000 claims description 24
- 102100032494 Pseudouridylate synthase 7 homolog Human genes 0.000 claims description 24
- 229910052796 boron Inorganic materials 0.000 claims description 23
- 239000000556 agonist Substances 0.000 claims description 22
- 101001111742 Homo sapiens Rhombotin-2 Proteins 0.000 claims description 20
- 102100023876 Rhombotin-2 Human genes 0.000 claims description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims description 13
- 230000003247 decreasing effect Effects 0.000 claims description 13
- 239000012188 paraffin wax Substances 0.000 claims description 10
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 9
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 9
- 239000013610 patient sample Substances 0.000 claims description 9
- 102100032937 CD40 ligand Human genes 0.000 claims description 8
- 238000004364 calculation method Methods 0.000 claims description 8
- 201000003444 follicular lymphoma Diseases 0.000 claims description 8
- 108010029697 CD40 Ligand Proteins 0.000 claims description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- 238000001574 biopsy Methods 0.000 claims description 6
- 208000021937 marginal zone lymphoma Diseases 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 5
- 238000011529 RT qPCR Methods 0.000 claims description 4
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims description 4
- 102100021035 Regulator of G-protein signaling 18 Human genes 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 description 68
- 238000003556 assay Methods 0.000 description 51
- 102100035776 Regulator of G-protein signaling 13 Human genes 0.000 description 41
- -1 LM02 Proteins 0.000 description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 32
- 201000010099 disease Diseases 0.000 description 29
- 230000027455 binding Effects 0.000 description 28
- 239000000090 biomarker Substances 0.000 description 28
- 108020004999 messenger RNA Proteins 0.000 description 27
- 230000008859 change Effects 0.000 description 25
- 239000000758 substrate Substances 0.000 description 23
- 108091034117 Oligonucleotide Proteins 0.000 description 22
- 102000040430 polynucleotide Human genes 0.000 description 22
- 108091033319 polynucleotide Proteins 0.000 description 22
- 239000002157 polynucleotide Substances 0.000 description 22
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 22
- 230000000875 corresponding effect Effects 0.000 description 20
- 102000055120 MEF2 Transcription Factors Human genes 0.000 description 19
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 19
- 239000000427 antigen Substances 0.000 description 19
- 150000007523 nucleic acids Chemical group 0.000 description 19
- 108091007433 antigens Proteins 0.000 description 18
- 102000036639 antigens Human genes 0.000 description 18
- 108090000765 processed proteins & peptides Proteins 0.000 description 18
- 230000004044 response Effects 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 229920001184 polypeptide Polymers 0.000 description 17
- 102000004196 processed proteins & peptides Human genes 0.000 description 17
- 238000002493 microarray Methods 0.000 description 16
- 102000039446 nucleic acids Human genes 0.000 description 16
- 108020004707 nucleic acids Proteins 0.000 description 16
- 125000003729 nucleotide group Chemical group 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 108060003951 Immunoglobulin Proteins 0.000 description 14
- 102000018358 immunoglobulin Human genes 0.000 description 14
- 238000003364 immunohistochemistry Methods 0.000 description 14
- 230000009467 reduction Effects 0.000 description 14
- 210000003719 b-lymphocyte Anatomy 0.000 description 12
- 238000009396 hybridization Methods 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 108091006207 SLC-Transporter Proteins 0.000 description 11
- 102000037054 SLC-Transporter Human genes 0.000 description 11
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 238000010186 staining Methods 0.000 description 11
- 238000013518 transcription Methods 0.000 description 11
- 230000035897 transcription Effects 0.000 description 11
- 102100030374 Actin, cytoplasmic 2 Human genes 0.000 description 10
- 101000773237 Homo sapiens Actin, cytoplasmic 2 Proteins 0.000 description 10
- 101001026232 Homo sapiens Small conductance calcium-activated potassium channel protein 3 Proteins 0.000 description 10
- 102100037442 Small conductance calcium-activated potassium channel protein 3 Human genes 0.000 description 10
- 230000003321 amplification Effects 0.000 description 10
- 238000001514 detection method Methods 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- 230000007170 pathology Effects 0.000 description 10
- 102100026894 Lymphotoxin-beta Human genes 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 238000003757 reverse transcription PCR Methods 0.000 description 9
- 230000002441 reversible effect Effects 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 101001112229 Homo sapiens Neutrophil cytosol factor 1 Proteins 0.000 description 8
- 101001045695 Homo sapiens Phosphoribosyl pyrophosphate synthase-associated protein 2 Proteins 0.000 description 8
- 101000789800 Homo sapiens Protein YIPF3 Proteins 0.000 description 8
- 101001051777 Homo sapiens Protein kinase C alpha type Proteins 0.000 description 8
- 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 description 8
- 101000965721 Homo sapiens Volume-regulated anion channel subunit LRRC8A Proteins 0.000 description 8
- 102100023620 Neutrophil cytosol factor 1 Human genes 0.000 description 8
- 102100022060 Phosphoribosyl pyrophosphate synthase-associated protein 2 Human genes 0.000 description 8
- 102100031292 Prepronociceptin Human genes 0.000 description 8
- 102100028077 Protein YIPF3 Human genes 0.000 description 8
- 102100024924 Protein kinase C alpha type Human genes 0.000 description 8
- 102100021947 Survival motor neuron protein Human genes 0.000 description 8
- 102100040985 Volume-regulated anion channel subunit LRRC8A Human genes 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 238000003491 array Methods 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 8
- 238000003753 real-time PCR Methods 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 108010078791 Carrier Proteins Proteins 0.000 description 7
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 description 7
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 description 7
- 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 description 7
- 101001129365 Homo sapiens Prepronociceptin Proteins 0.000 description 7
- 102100029571 Immunoglobulin J chain Human genes 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 230000004075 alteration Effects 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 230000002596 correlated effect Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 239000003623 enhancer Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000013074 reference sample Substances 0.000 description 7
- 229960004641 rituximab Drugs 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 102100033890 Arylsulfatase G Human genes 0.000 description 6
- 102100024220 CD180 antigen Human genes 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 108091006146 Channels Proteins 0.000 description 6
- 102100032644 Copine-2 Human genes 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 102100030801 Elongation factor 1-alpha 1 Human genes 0.000 description 6
- 101000980829 Homo sapiens CD180 antigen Proteins 0.000 description 6
- 101000920078 Homo sapiens Elongation factor 1-alpha 1 Proteins 0.000 description 6
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
- 108060006456 POU2AF1 Proteins 0.000 description 6
- 102000036938 POU2AF1 Human genes 0.000 description 6
- 206010035226 Plasma cell myeloma Diseases 0.000 description 6
- 102100020950 Polypeptide N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 102100029197 SLAM family member 6 Human genes 0.000 description 6
- 102100035303 Transmembrane protein 87A Human genes 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 239000003593 chromogenic compound Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000010199 gene set enrichment analysis Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000010606 normalization Methods 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 230000019491 signal transduction Effects 0.000 description 6
- 230000011664 signaling Effects 0.000 description 6
- 102100024419 28S ribosomal protein S31, mitochondrial Human genes 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 102100021763 Alpha-mannosidase 2x Human genes 0.000 description 5
- 102100034270 Ankyrin repeat domain-containing protein 13A Human genes 0.000 description 5
- 108091008875 B cell receptors Proteins 0.000 description 5
- 102100021259 Frizzled-1 Human genes 0.000 description 5
- 102100039996 Histone deacetylase 1 Human genes 0.000 description 5
- 101000689847 Homo sapiens 28S ribosomal protein S31, mitochondrial Proteins 0.000 description 5
- 101000615966 Homo sapiens Alpha-mannosidase 2x Proteins 0.000 description 5
- 101000780149 Homo sapiens Ankyrin repeat domain-containing protein 13A Proteins 0.000 description 5
- 101000819438 Homo sapiens Frizzled-1 Proteins 0.000 description 5
- 101001006875 Homo sapiens Kelch-like protein 23 Proteins 0.000 description 5
- 101001109719 Homo sapiens Nucleophosmin Proteins 0.000 description 5
- 101000764357 Homo sapiens Protein Tob1 Proteins 0.000 description 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 102100027795 Kelch-like protein 23 Human genes 0.000 description 5
- 102100022678 Nucleophosmin Human genes 0.000 description 5
- 238000000692 Student's t-test Methods 0.000 description 5
- 102100030633 TATA box-binding protein-like 1 Human genes 0.000 description 5
- 230000030833 cell death Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000012353 t test Methods 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 102100031571 40S ribosomal protein S16 Human genes 0.000 description 4
- 102100033051 40S ribosomal protein S19 Human genes 0.000 description 4
- 102100024442 60S ribosomal protein L13 Human genes 0.000 description 4
- 102100037685 60S ribosomal protein L22 Human genes 0.000 description 4
- 102100022936 ATPase inhibitor, mitochondrial Human genes 0.000 description 4
- 206010073478 Anaplastic large-cell lymphoma Diseases 0.000 description 4
- 102000004360 Cofilin 1 Human genes 0.000 description 4
- 108090000996 Cofilin 1 Proteins 0.000 description 4
- 102100029588 Deoxycytidine kinase Human genes 0.000 description 4
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- 102100029652 EH domain-binding protein 1 Human genes 0.000 description 4
- 102100023362 Elongation factor 1-gamma Human genes 0.000 description 4
- 101000691550 Homo sapiens 39S ribosomal protein L13, mitochondrial Proteins 0.000 description 4
- 101000706746 Homo sapiens 40S ribosomal protein S16 Proteins 0.000 description 4
- 101000733040 Homo sapiens 40S ribosomal protein S19 Proteins 0.000 description 4
- 101001118201 Homo sapiens 60S ribosomal protein L13 Proteins 0.000 description 4
- 101001097555 Homo sapiens 60S ribosomal protein L22 Proteins 0.000 description 4
- 101001050451 Homo sapiens Elongation factor 1-gamma Proteins 0.000 description 4
- 101001055087 Homo sapiens MAP3K7 C-terminal-like protein Proteins 0.000 description 4
- 101001013272 Homo sapiens Mediator of RNA polymerase II transcription subunit 29 Proteins 0.000 description 4
- 101001138006 Homo sapiens Purine nucleoside phosphorylase LACC1 Proteins 0.000 description 4
- 101000602187 Homo sapiens Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta Proteins 0.000 description 4
- 101000650547 Homo sapiens Ribosome production factor 1 Proteins 0.000 description 4
- 101001102797 Homo sapiens Transmembrane protein PVRIG Proteins 0.000 description 4
- 101000727826 Homo sapiens Tyrosine-protein kinase RYK Proteins 0.000 description 4
- 101000608019 Homo sapiens USP6 N-terminal-like protein Proteins 0.000 description 4
- 101000854918 Homo sapiens WD repeat-containing protein 6 Proteins 0.000 description 4
- 102100036091 Kynureninase Human genes 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 208000032004 Large-Cell Anaplastic Lymphoma Diseases 0.000 description 4
- 102100026906 MAP3K7 C-terminal-like protein Human genes 0.000 description 4
- 102100029668 Mediator of RNA polymerase II transcription subunit 29 Human genes 0.000 description 4
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 4
- 108700020796 Oncogene Proteins 0.000 description 4
- 102100025909 Opsin-3 Human genes 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 102100035457 Paraneoplastic antigen Ma1 Human genes 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 102100020863 Purine nucleoside phosphorylase LACC1 Human genes 0.000 description 4
- 102100037593 Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta Human genes 0.000 description 4
- 102100027482 Ribosome production factor 1 Human genes 0.000 description 4
- 102100034447 Serine/threonine-protein kinase NLK Human genes 0.000 description 4
- 102100030113 Sulfate transporter Human genes 0.000 description 4
- 102100035317 Transmembrane protein 17 Human genes 0.000 description 4
- 102100036756 Transmembrane protein 64 Human genes 0.000 description 4
- 102100039630 Transmembrane protein PVRIG Human genes 0.000 description 4
- 102100040418 Tumor protein D52 Human genes 0.000 description 4
- 102100029759 Tyrosine-protein kinase RYK Human genes 0.000 description 4
- 102100039854 USP6 N-terminal-like protein Human genes 0.000 description 4
- 102100020706 WD repeat-containing protein 6 Human genes 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 102100028366 Zinc finger protein 322 Human genes 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 4
- 230000021615 conjugation Effects 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 238000007901 in situ hybridization Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000003147 molecular marker Substances 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 238000007447 staining method Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 102100026744 40S ribosomal protein S10 Human genes 0.000 description 3
- 102100023779 40S ribosomal protein S5 Human genes 0.000 description 3
- PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 description 3
- 102100021660 60S ribosomal protein L28 Human genes 0.000 description 3
- 102100041029 60S ribosomal protein L9 Human genes 0.000 description 3
- 102100038079 AP2-associated protein kinase 1 Human genes 0.000 description 3
- 102100027691 ATP synthase membrane subunit K, mitochondrial Human genes 0.000 description 3
- 108091006112 ATPases Proteins 0.000 description 3
- 102100032872 Adenosine 3'-phospho 5'-phosphosulfate transporter 1 Human genes 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- 102100028225 Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 Human genes 0.000 description 3
- 101710115232 Arylsulfatase G Proteins 0.000 description 3
- 102100034691 Astrocytic phosphoprotein PEA-15 Human genes 0.000 description 3
- 108090001008 Avidin Proteins 0.000 description 3
- 102100040755 CREB-regulated transcription coactivator 3 Human genes 0.000 description 3
- 102100023241 Calcium-activated potassium channel subunit beta-4 Human genes 0.000 description 3
- 102100029226 Cancer-related nucleoside-triphosphatase Human genes 0.000 description 3
- 102100028003 Catenin alpha-1 Human genes 0.000 description 3
- 102100021216 Cleft lip and palate transmembrane protein 1 Human genes 0.000 description 3
- 102100025411 Coiled-coil domain-containing protein 144B Human genes 0.000 description 3
- 102100023774 Cold-inducible RNA-binding protein Human genes 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 101710125101 Copine-2 Proteins 0.000 description 3
- 102100032643 Copine-5 Human genes 0.000 description 3
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 3
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 3
- 108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 description 3
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 3
- 206010061818 Disease progression Diseases 0.000 description 3
- 102100028555 Disheveled-associated activator of morphogenesis 1 Human genes 0.000 description 3
- 102100040573 ELL-associated factor 2 Human genes 0.000 description 3
- 102100037250 EP300-interacting inhibitor of differentiation 1 Human genes 0.000 description 3
- 102100036437 Ectonucleoside triphosphate diphosphohydrolase 6 Human genes 0.000 description 3
- 101150073167 Eif1 gene Proteins 0.000 description 3
- 102100039328 Endoplasmin Human genes 0.000 description 3
- 108700039887 Essential Genes Proteins 0.000 description 3
- 102100029775 Eukaryotic translation initiation factor 1 Human genes 0.000 description 3
- 102100030861 Eyes absent homolog 3 Human genes 0.000 description 3
- 102100038651 Four and a half LIM domains protein 1 Human genes 0.000 description 3
- 102100040287 GTP cyclohydrolase 1 feedback regulatory protein Human genes 0.000 description 3
- 102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 3
- 108010024124 Histone Deacetylase 1 Proteins 0.000 description 3
- 208000017604 Hodgkin disease Diseases 0.000 description 3
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 3
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 3
- 101001119189 Homo sapiens 40S ribosomal protein S10 Proteins 0.000 description 3
- 101000622644 Homo sapiens 40S ribosomal protein S5 Proteins 0.000 description 3
- 101000676271 Homo sapiens 60S ribosomal protein L28 Proteins 0.000 description 3
- 101000672886 Homo sapiens 60S ribosomal protein L9 Proteins 0.000 description 3
- 101000742699 Homo sapiens AP2-associated protein kinase 1 Proteins 0.000 description 3
- 101000937382 Homo sapiens ATP synthase membrane subunit K, mitochondrial Proteins 0.000 description 3
- 101000724279 Homo sapiens Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 Proteins 0.000 description 3
- 101000925538 Homo sapiens Arylsulfatase G Proteins 0.000 description 3
- 101000984916 Homo sapiens Butyrophilin subfamily 3 member A3 Proteins 0.000 description 3
- 101000891906 Homo sapiens CREB-regulated transcription coactivator 3 Proteins 0.000 description 3
- 101001049842 Homo sapiens Calcium-activated potassium channel subunit beta-4 Proteins 0.000 description 3
- 101001124534 Homo sapiens Cancer-related nucleoside-triphosphatase Proteins 0.000 description 3
- 101000750204 Homo sapiens Cleft lip and palate transmembrane protein 1 Proteins 0.000 description 3
- 101000934952 Homo sapiens Coiled-coil domain-containing protein 144B Proteins 0.000 description 3
- 101000941777 Homo sapiens Copine-2 Proteins 0.000 description 3
- 101000908138 Homo sapiens Cyclin-dependent kinase 10 Proteins 0.000 description 3
- 101000915413 Homo sapiens Disheveled-associated activator of morphogenesis 1 Proteins 0.000 description 3
- 101000881670 Homo sapiens EP300-interacting inhibitor of differentiation 1 Proteins 0.000 description 3
- 101000812663 Homo sapiens Endoplasmin Proteins 0.000 description 3
- 101000938441 Homo sapiens Eyes absent homolog 3 Proteins 0.000 description 3
- 101001031607 Homo sapiens Four and a half LIM domains protein 1 Proteins 0.000 description 3
- 101001038346 Homo sapiens GTP cyclohydrolase 1 feedback regulatory protein Proteins 0.000 description 3
- 101000971697 Homo sapiens Kinesin-like protein KIF1B Proteins 0.000 description 3
- 101001021858 Homo sapiens Kynureninase Proteins 0.000 description 3
- 101001043352 Homo sapiens Lysyl oxidase homolog 2 Proteins 0.000 description 3
- 101000579857 Homo sapiens PC-esterase domain-containing protein 1B Proteins 0.000 description 3
- 101001133656 Homo sapiens Plasminogen activator inhibitor 1 RNA-binding protein Proteins 0.000 description 3
- 101000730605 Homo sapiens Pleckstrin homology domain-containing family F member 2 Proteins 0.000 description 3
- 101001069601 Homo sapiens Probable G-protein coupled receptor 82 Proteins 0.000 description 3
- 101000873612 Homo sapiens Protein bicaudal D homolog 1 Proteins 0.000 description 3
- 101000861587 Homo sapiens Protein farnesyltransferase subunit beta Proteins 0.000 description 3
- 101000640056 Homo sapiens Protein strawberry notch homolog 2 Proteins 0.000 description 3
- 101001123986 Homo sapiens Protein-serine O-palmitoleoyltransferase porcupine Proteins 0.000 description 3
- 101000686227 Homo sapiens Ras-related protein R-Ras2 Proteins 0.000 description 3
- 101001094531 Homo sapiens Reticulon-4-interacting protein 1, mitochondrial Proteins 0.000 description 3
- 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 description 3
- 101000989953 Homo sapiens Serine/threonine-protein kinase haspin Proteins 0.000 description 3
- 101000648042 Homo sapiens Signal-transducing adaptor protein 1 Proteins 0.000 description 3
- 101000673946 Homo sapiens Synaptotagmin-like protein 1 Proteins 0.000 description 3
- 101000845194 Homo sapiens Tetratricopeptide repeat protein 9A Proteins 0.000 description 3
- 101000658157 Homo sapiens Thymosin beta-4 Proteins 0.000 description 3
- 101000933542 Homo sapiens Transcription factor BTF3 Proteins 0.000 description 3
- 101000801038 Homo sapiens Translation machinery-associated protein 7 Proteins 0.000 description 3
- 101000597830 Homo sapiens Transmembrane protein 87A Proteins 0.000 description 3
- 101000850794 Homo sapiens Tropomyosin alpha-3 chain Proteins 0.000 description 3
- 101000887051 Homo sapiens Ubiquitin-like-conjugating enzyme ATG3 Proteins 0.000 description 3
- 101000944530 Homo sapiens Uncharacterized protein C6orf62 Proteins 0.000 description 3
- 101150065069 Hsp90b1 gene Proteins 0.000 description 3
- 102100036343 Inositol 1,4,5-triphosphate receptor associated 2 Human genes 0.000 description 3
- 102100021524 Kinesin-like protein KIF1B Human genes 0.000 description 3
- 102100026033 LIM domain-containing protein 1 Human genes 0.000 description 3
- 206010024612 Lipoma Diseases 0.000 description 3
- 102000018247 Lymphocyte-specific proteins Human genes 0.000 description 3
- 108050007388 Lymphocyte-specific proteins Proteins 0.000 description 3
- 102100021948 Lysyl oxidase homolog 2 Human genes 0.000 description 3
- 102000018697 Membrane Proteins Human genes 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000034578 Multiple myelomas Diseases 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 102100022883 Nuclear receptor coactivator 3 Human genes 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 101710130961 Opsin-3 Proteins 0.000 description 3
- 102100027501 PC-esterase domain-containing protein 1B Human genes 0.000 description 3
- 238000010222 PCR analysis Methods 0.000 description 3
- 229940122344 Peptidase inhibitor Drugs 0.000 description 3
- 102000004246 Phakinin Human genes 0.000 description 3
- 108090000709 Phakinin Proteins 0.000 description 3
- 102100034055 Plasminogen activator inhibitor 1 RNA-binding protein Human genes 0.000 description 3
- 102100040682 Platelet-derived growth factor D Human genes 0.000 description 3
- 102100032593 Pleckstrin homology domain-containing family F member 2 Human genes 0.000 description 3
- 102000010995 Pleckstrin homology domains Human genes 0.000 description 3
- 108050001185 Pleckstrin homology domains Proteins 0.000 description 3
- 108010066816 Polypeptide N-acetylgalactosaminyltransferase Proteins 0.000 description 3
- 102100033866 Probable G-protein coupled receptor 82 Human genes 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 102100026881 Protein Tob1 Human genes 0.000 description 3
- 102100035898 Protein bicaudal D homolog 1 Human genes 0.000 description 3
- 102100027569 Protein farnesyltransferase subunit beta Human genes 0.000 description 3
- 102100033980 Protein strawberry notch homolog 2 Human genes 0.000 description 3
- 102100028119 Protein-serine O-palmitoleoyltransferase porcupine Human genes 0.000 description 3
- 102100021315 Rab11 family-interacting protein 1 Human genes 0.000 description 3
- 102100033450 Ras guanyl-releasing protein 3 Human genes 0.000 description 3
- 102100025003 Ras-related protein R-Ras2 Human genes 0.000 description 3
- 102100035121 Reticulon-4-interacting protein 1, mitochondrial Human genes 0.000 description 3
- 101710083278 SLAM family member 6 Proteins 0.000 description 3
- 108091006505 SLC26A2 Proteins 0.000 description 3
- 102000009203 Sema domains Human genes 0.000 description 3
- 108050000099 Sema domains Proteins 0.000 description 3
- 102000014105 Semaphorin Human genes 0.000 description 3
- 108050003978 Semaphorin Proteins 0.000 description 3
- 102100029332 Serine/threonine-protein kinase haspin Human genes 0.000 description 3
- 102000008847 Serpin Human genes 0.000 description 3
- 108050000761 Serpin Proteins 0.000 description 3
- 102100025263 Signal-transducing adaptor protein 1 Human genes 0.000 description 3
- 102100040541 Synaptotagmin-like protein 1 Human genes 0.000 description 3
- 101710172903 TATA box-binding protein-like 1 Proteins 0.000 description 3
- 102100031286 Tetratricopeptide repeat protein 9A Human genes 0.000 description 3
- 102100035000 Thymosin beta-4 Human genes 0.000 description 3
- 102100026043 Transcription factor BTF3 Human genes 0.000 description 3
- 102100033696 Translation machinery-associated protein 7 Human genes 0.000 description 3
- 101710190947 Transmembrane protein 87A Proteins 0.000 description 3
- 102100033080 Tropomyosin alpha-3 chain Human genes 0.000 description 3
- 102100039930 Ubiquitin-like-conjugating enzyme ATG3 Human genes 0.000 description 3
- 102100033655 Uncharacterized protein C6orf62 Human genes 0.000 description 3
- 102100024703 Zinc finger protein 32 Human genes 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 238000009175 antibody therapy Methods 0.000 description 3
- 230000005888 antibody-dependent cellular phagocytosis Effects 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000003081 coactivator Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000005750 disease progression Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 239000000834 fixative Substances 0.000 description 3
- 210000001280 germinal center Anatomy 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- 210000000107 myocyte Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 102000016914 ras Proteins Human genes 0.000 description 3
- 239000003001 serine protease inhibitor Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 238000011285 therapeutic regimen Methods 0.000 description 3
- 230000005945 translocation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QYNUQALWYRSVHF-OLZOCXBDSA-N (6R)-5,10-methylenetetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1C1)N)N1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-OLZOCXBDSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 2
- 102100038697 24-hydroxycholesterol 7-alpha-hydroxylase Human genes 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 2
- 102100036611 AN1-type zinc finger protein 4 Human genes 0.000 description 2
- 101710085568 ATPase inhibitor, mitochondrial Proteins 0.000 description 2
- 101000983256 Acanthamoeba polyphaga mimivirus Putative prolyl 4-hydroxylase Proteins 0.000 description 2
- 102100027166 Activating molecule in BECN1-regulated autophagy protein 1 Human genes 0.000 description 2
- 102100027647 Activin receptor type-2B Human genes 0.000 description 2
- 102100021626 Ankyrin repeat and SOCS box protein 2 Human genes 0.000 description 2
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 description 2
- 102000002785 Ataxin-10 Human genes 0.000 description 2
- 108010043914 Ataxin-10 Proteins 0.000 description 2
- 239000010755 BS 2869 Class G Substances 0.000 description 2
- 102100031042 CCR4-NOT transcription complex subunit 6-like Human genes 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 102000016362 Catenins Human genes 0.000 description 2
- 108010067316 Catenins Proteins 0.000 description 2
- 102000003902 Cathepsin C Human genes 0.000 description 2
- 108090000267 Cathepsin C Proteins 0.000 description 2
- 102100023263 Cyclin-dependent kinase 10 Human genes 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- 102000003849 Cytochrome P450 Human genes 0.000 description 2
- 102100038417 Cytoplasmic FMR1-interacting protein 1 Human genes 0.000 description 2
- 102100039315 Cytoplasmic polyadenylation element-binding protein 4 Human genes 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 108010033174 Deoxycytidine kinase Proteins 0.000 description 2
- 101001031598 Dictyostelium discoideum Probable serine/threonine-protein kinase fhkC Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102100022334 Dihydropyrimidine dehydrogenase [NADP(+)] Human genes 0.000 description 2
- 102100023149 E3 ubiquitin-protein ligase MARCHF6 Human genes 0.000 description 2
- 101710165824 EH domain-binding protein 1 Proteins 0.000 description 2
- 102100021598 Endoplasmic reticulum aminopeptidase 1 Human genes 0.000 description 2
- 101710168245 Endoplasmic reticulum aminopeptidase 1 Proteins 0.000 description 2
- 102100021579 Enhancer of filamentation 1 Human genes 0.000 description 2
- 102100031381 Fc receptor-like A Human genes 0.000 description 2
- 102100031512 Fc receptor-like protein 3 Human genes 0.000 description 2
- 108010087819 Fc receptors Proteins 0.000 description 2
- 102000009109 Fc receptors Human genes 0.000 description 2
- 102100030831 Fibrocystin-L Human genes 0.000 description 2
- 102100037813 Focal adhesion kinase 1 Human genes 0.000 description 2
- 102100021262 Frizzled-3 Human genes 0.000 description 2
- 108091006027 G proteins Proteins 0.000 description 2
- 102100023940 G-protein-signaling modulator 1 Human genes 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 102100021184 Golgi membrane protein 1 Human genes 0.000 description 2
- 108700010013 HMGB1 Proteins 0.000 description 2
- 101150021904 HMGB1 gene Proteins 0.000 description 2
- 102100026973 Heat shock protein 75 kDa, mitochondrial Human genes 0.000 description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 2
- 102100037848 Heterochromatin protein 1-binding protein 3 Human genes 0.000 description 2
- 102100037907 High mobility group protein B1 Human genes 0.000 description 2
- 102100039121 Histone-lysine N-methyltransferase MECOM Human genes 0.000 description 2
- 102100032827 Homeodomain-interacting protein kinase 2 Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000957683 Homo sapiens 24-hydroxycholesterol 7-alpha-hydroxylase Proteins 0.000 description 2
- 101000782079 Homo sapiens AN1-type zinc finger protein 4 Proteins 0.000 description 2
- 101000902767 Homo sapiens ATPase inhibitor, mitochondrial Proteins 0.000 description 2
- 101000836967 Homo sapiens Activating molecule in BECN1-regulated autophagy protein 1 Proteins 0.000 description 2
- 101000937269 Homo sapiens Activin receptor type-2B Proteins 0.000 description 2
- 101000732617 Homo sapiens Angiotensinogen Proteins 0.000 description 2
- 101000754299 Homo sapiens Ankyrin repeat and SOCS box protein 2 Proteins 0.000 description 2
- 101000734668 Homo sapiens Astrocytic phosphoprotein PEA-15 Proteins 0.000 description 2
- 101000919666 Homo sapiens CCR4-NOT transcription complex subunit 6-like Proteins 0.000 description 2
- 101000859063 Homo sapiens Catenin alpha-1 Proteins 0.000 description 2
- 101000906744 Homo sapiens Cold-inducible RNA-binding protein Proteins 0.000 description 2
- 101000941772 Homo sapiens Copine-5 Proteins 0.000 description 2
- 101000745636 Homo sapiens Cytoplasmic polyadenylation element-binding protein 4 Proteins 0.000 description 2
- 101000930289 Homo sapiens DNA methyltransferase 1-associated protein 1 Proteins 0.000 description 2
- 101000978676 Homo sapiens E3 ubiquitin-protein ligase MARCHF6 Proteins 0.000 description 2
- 101001012951 Homo sapiens EH domain-binding protein 1 Proteins 0.000 description 2
- 101000966913 Homo sapiens ELL-associated factor 2 Proteins 0.000 description 2
- 101000851972 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 6 Proteins 0.000 description 2
- 101000898310 Homo sapiens Enhancer of filamentation 1 Proteins 0.000 description 2
- 101000846860 Homo sapiens Fc receptor-like A Proteins 0.000 description 2
- 101000846910 Homo sapiens Fc receptor-like protein 3 Proteins 0.000 description 2
- 101000583237 Homo sapiens Fibrocystin-L Proteins 0.000 description 2
- 101000878536 Homo sapiens Focal adhesion kinase 1 Proteins 0.000 description 2
- 101000819458 Homo sapiens Frizzled-3 Proteins 0.000 description 2
- 101000904748 Homo sapiens G-protein-signaling modulator 1 Proteins 0.000 description 2
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 2
- 101000871017 Homo sapiens Growth factor receptor-bound protein 2 Proteins 0.000 description 2
- 101001025546 Homo sapiens Heterochromatin protein 1-binding protein 3 Proteins 0.000 description 2
- 101001035024 Homo sapiens Histone deacetylase 1 Proteins 0.000 description 2
- 101001033728 Homo sapiens Histone-lysine N-methyltransferase MECOM Proteins 0.000 description 2
- 101000852486 Homo sapiens Inositol 1,4,5-triphosphate receptor associated 2 Proteins 0.000 description 2
- 101001008854 Homo sapiens Kelch-like protein 6 Proteins 0.000 description 2
- 101000971879 Homo sapiens Kell blood group glycoprotein Proteins 0.000 description 2
- 101001008949 Homo sapiens Kinesin-like protein KIF14 Proteins 0.000 description 2
- 101001051207 Homo sapiens L-lactate dehydrogenase B chain Proteins 0.000 description 2
- 101001005101 Homo sapiens LIM domain-containing protein 1 Proteins 0.000 description 2
- 101001065853 Homo sapiens Leucine repeat adapter protein 25 Proteins 0.000 description 2
- 101000575066 Homo sapiens Mediator of RNA polymerase II transcription subunit 17 Proteins 0.000 description 2
- 101000956317 Homo sapiens Membrane-spanning 4-domains subfamily A member 4A Proteins 0.000 description 2
- 101001014567 Homo sapiens Membrane-spanning 4-domains subfamily A member 7 Proteins 0.000 description 2
- 101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 description 2
- 101000593398 Homo sapiens Myb-related protein A Proteins 0.000 description 2
- 101000624956 Homo sapiens Nesprin-2 Proteins 0.000 description 2
- 101000974356 Homo sapiens Nuclear receptor coactivator 3 Proteins 0.000 description 2
- 101001094802 Homo sapiens Paraneoplastic antigen Ma1 Proteins 0.000 description 2
- 101000873719 Homo sapiens Phakinin Proteins 0.000 description 2
- 101001074628 Homo sapiens Phosphatidylinositol-glycan biosynthesis class W protein Proteins 0.000 description 2
- 101000701367 Homo sapiens Phospholipid-transporting ATPase IA Proteins 0.000 description 2
- 101000728117 Homo sapiens Plasma membrane calcium-transporting ATPase 4 Proteins 0.000 description 2
- 101000611892 Homo sapiens Platelet-derived growth factor D Proteins 0.000 description 2
- 101001002235 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 2 Proteins 0.000 description 2
- 101001122811 Homo sapiens Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 Proteins 0.000 description 2
- 101000887210 Homo sapiens Probable cation-transporting ATPase 13A5 Proteins 0.000 description 2
- 101001072202 Homo sapiens Protein disulfide-isomerase Proteins 0.000 description 2
- 101000685918 Homo sapiens Protein transport protein Sec23A Proteins 0.000 description 2
- 101000822032 Homo sapiens Putative sodium-coupled neutral amino acid transporter 7 Proteins 0.000 description 2
- 101000620788 Homo sapiens Rab proteins geranylgeranyltransferase component A 2 Proteins 0.000 description 2
- 101001106821 Homo sapiens Rab11 family-interacting protein 1 Proteins 0.000 description 2
- 101000870945 Homo sapiens Ras guanyl-releasing protein 3 Proteins 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- 101001092147 Homo sapiens Regulator of G-protein signaling 13 Proteins 0.000 description 2
- 101000669917 Homo sapiens Rho-associated protein kinase 1 Proteins 0.000 description 2
- 101000974043 Homo sapiens Ribosome biogenesis protein NOP53 Proteins 0.000 description 2
- 101000650814 Homo sapiens Semaphorin-4C Proteins 0.000 description 2
- 101000632054 Homo sapiens Septin-8 Proteins 0.000 description 2
- 101000701876 Homo sapiens Serpin A9 Proteins 0.000 description 2
- 101000878981 Homo sapiens Squalene synthase Proteins 0.000 description 2
- 101000653503 Homo sapiens TATA box-binding protein-like 1 Proteins 0.000 description 2
- 101000837639 Homo sapiens Thyroxine-binding globulin Proteins 0.000 description 2
- 101000687727 Homo sapiens Transcriptional regulator PINT87aa Proteins 0.000 description 2
- 101000597750 Homo sapiens Transmembrane protein 17 Proteins 0.000 description 2
- 101000851550 Homo sapiens Transmembrane protein 64 Proteins 0.000 description 2
- 101000610980 Homo sapiens Tumor protein D52 Proteins 0.000 description 2
- 101000638903 Homo sapiens U3 small nucleolar RNA-associated protein 25 homolog Proteins 0.000 description 2
- 101000777156 Homo sapiens UBX domain-containing protein 4 Proteins 0.000 description 2
- 101000956262 Homo sapiens UPF0692 protein C19orf54 Proteins 0.000 description 2
- 101000806601 Homo sapiens V-type proton ATPase catalytic subunit A Proteins 0.000 description 2
- 101000650141 Homo sapiens WAS/WASL-interacting protein family member 1 Proteins 0.000 description 2
- 101000788842 Homo sapiens Zinc finger and BTB domain-containing protein 9 Proteins 0.000 description 2
- 101000760284 Homo sapiens Zinc finger protein 32 Proteins 0.000 description 2
- 101000723710 Homo sapiens Zinc finger protein 322 Proteins 0.000 description 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
- 102100027791 Kelch-like protein 6 Human genes 0.000 description 2
- 102100021447 Kell blood group glycoprotein Human genes 0.000 description 2
- 102100027631 Kinesin-like protein KIF14 Human genes 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 102100024580 L-lactate dehydrogenase B chain Human genes 0.000 description 2
- 102100032097 Leucine repeat adapter protein 25 Human genes 0.000 description 2
- 102000003959 Lymphotoxin-beta Human genes 0.000 description 2
- 108090000362 Lymphotoxin-beta Proteins 0.000 description 2
- 108091007767 MALAT1 Proteins 0.000 description 2
- 102100025530 Mediator of RNA polymerase II transcription subunit 17 Human genes 0.000 description 2
- 102100032512 Membrane-spanning 4-domains subfamily A member 7 Human genes 0.000 description 2
- 102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 102100034711 Myb-related protein A Human genes 0.000 description 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 2
- 102100023305 Nesprin-2 Human genes 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108091014659 POZ domain binding proteins Proteins 0.000 description 2
- 102000025443 POZ domain binding proteins Human genes 0.000 description 2
- 108050008040 Paraneoplastic antigen Ma1 Proteins 0.000 description 2
- 102100035832 Phakinin Human genes 0.000 description 2
- 102100036253 Phosphatidylinositol-glycan biosynthesis class W protein Human genes 0.000 description 2
- 102100030622 Phospholipid-transporting ATPase IA Human genes 0.000 description 2
- 102100029743 Plasma membrane calcium-transporting ATPase 4 Human genes 0.000 description 2
- 102100028729 Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 Human genes 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 102100039912 Probable cation-transporting ATPase 13A5 Human genes 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 2
- 102100036352 Protein disulfide-isomerase Human genes 0.000 description 2
- 102100023365 Protein transport protein Sec23A Human genes 0.000 description 2
- 108010039518 Proton-Translocating ATPases Proteins 0.000 description 2
- 102000015176 Proton-Translocating ATPases Human genes 0.000 description 2
- 102100021471 Putative sodium-coupled neutral amino acid transporter 7 Human genes 0.000 description 2
- 102100025165 Rab GTPase-activating protein 1-like, isoform 10 Human genes 0.000 description 2
- 102100022880 Rab proteins geranylgeranyltransferase component A 2 Human genes 0.000 description 2
- 102100023320 Ral guanine nucleotide dissociation stimulator Human genes 0.000 description 2
- 101150015043 Ralgds gene Proteins 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102100039313 Rho-associated protein kinase 1 Human genes 0.000 description 2
- 102100022399 Ribosome biogenesis protein NOP53 Human genes 0.000 description 2
- 108091006593 SLC15A2 Proteins 0.000 description 2
- 108091006525 SLC27A2 Proteins 0.000 description 2
- 108091006549 SLC30A1 Proteins 0.000 description 2
- 108091006950 SLC35B2 Proteins 0.000 description 2
- 102000005034 SLC6A16 Human genes 0.000 description 2
- 108060007755 SLC6A16 Proteins 0.000 description 2
- 102100027745 Semaphorin-4C Human genes 0.000 description 2
- 102000044463 Septin 8 Human genes 0.000 description 2
- 108700036698 Septin 8 Proteins 0.000 description 2
- 102100028025 Septin-8 Human genes 0.000 description 2
- 101710116197 Serine/threonine kinase NLK Proteins 0.000 description 2
- 101710175706 Serine/threonine-protein kinase NLK Proteins 0.000 description 2
- 102100030420 Serpin A9 Human genes 0.000 description 2
- 102100022824 Serum paraoxonase/arylesterase 2 Human genes 0.000 description 2
- 102100021488 Solute carrier family 15 member 2 Human genes 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 102100037997 Squalene synthase Human genes 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 102100028196 Threonine-tRNA ligase 2, cytoplasmic Human genes 0.000 description 2
- 102100028709 Thyroxine-binding globulin Human genes 0.000 description 2
- 102000019347 Tob1 Human genes 0.000 description 2
- 102100024797 Transcriptional regulator PINT87aa Human genes 0.000 description 2
- 101710103132 Transmembrane protein 17 Proteins 0.000 description 2
- 101710106923 Transmembrane protein 64 Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 101710190247 Tumor protein D52 Proteins 0.000 description 2
- 102100031542 U3 small nucleolar RNA-associated protein 25 homolog Human genes 0.000 description 2
- 102100031308 UBX domain-containing protein 4 Human genes 0.000 description 2
- LFTYTUAZOPRMMI-NESSUJCYSA-N UDP-N-acetyl-alpha-D-galactosamine Chemical compound O1[C@H](CO)[C@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-NESSUJCYSA-N 0.000 description 2
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 2
- 102100038574 UPF0692 protein C19orf54 Human genes 0.000 description 2
- 102100037466 V-type proton ATPase catalytic subunit A Human genes 0.000 description 2
- 102100023048 Very long-chain acyl-CoA synthetase Human genes 0.000 description 2
- 101710175177 Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 2
- 102100037438 Very-long-chain 3-oxoacyl-CoA reductase Human genes 0.000 description 2
- 101710187138 Very-long-chain 3-oxoacyl-CoA reductase-A Proteins 0.000 description 2
- 101710187143 Very-long-chain 3-oxoacyl-CoA reductase-B Proteins 0.000 description 2
- 102100027538 WAS/WASL-interacting protein family member 1 Human genes 0.000 description 2
- 102100025397 Zinc finger and BTB domain-containing protein 9 Human genes 0.000 description 2
- 101710146937 Zinc finger protein 322 Proteins 0.000 description 2
- 102100034993 Zinc transporter 1 Human genes 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000002820 assay format Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 2
- 229940020967 gemzar Drugs 0.000 description 2
- 238000012224 gene deletion Methods 0.000 description 2
- 238000011223 gene expression profiling Methods 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 2
- 239000012642 immune effector Substances 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007919 lymphoplasmacytic lymphoma Diseases 0.000 description 2
- 230000002132 lysosomal effect Effects 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012775 microarray technology Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 201000005962 mycosis fungoides Diseases 0.000 description 2
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 238000009520 phase I clinical trial Methods 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 229920002791 poly-4-hydroxybutyrate Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 208000019814 splenic diffuse large B-cell lymphoma Diseases 0.000 description 2
- 206010062113 splenic marginal zone lymphoma Diseases 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 102100027832 14-3-3 protein gamma Human genes 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical class C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 description 1
- AQQSXKSWTNWXKR-UHFFFAOYSA-N 2-(2-phenylphenanthro[9,10-d]imidazol-3-yl)acetic acid Chemical compound C1(=CC=CC=C1)C1=NC2=C(N1CC(=O)O)C1=CC=CC=C1C=1C=CC=CC=12 AQQSXKSWTNWXKR-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 102100027824 3'(2'),5'-bisphosphate nucleotidase 1 Human genes 0.000 description 1
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- OBWSOTREAMFOCQ-UHFFFAOYSA-N 4-(4-amino-3,5-dimethylphenyl)-2,6-dimethylaniline;hydrochloride Chemical compound Cl.CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 OBWSOTREAMFOCQ-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 102100023216 40S ribosomal protein S15 Human genes 0.000 description 1
- 102100037563 40S ribosomal protein S2 Human genes 0.000 description 1
- 102100022600 40S ribosomal protein S3a Human genes 0.000 description 1
- 102100027271 40S ribosomal protein SA Human genes 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 102100022406 60S ribosomal protein L10a Human genes 0.000 description 1
- 102100022289 60S ribosomal protein L13a Human genes 0.000 description 1
- 102100026926 60S ribosomal protein L4 Human genes 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 208000035657 Abasia Diseases 0.000 description 1
- 102100033404 Acidic leucine-rich nuclear phosphoprotein 32 family member E Human genes 0.000 description 1
- 102000042089 Actin family Human genes 0.000 description 1
- 108091080272 Actin family Proteins 0.000 description 1
- 102100022734 Acyl carrier protein, mitochondrial Human genes 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 108010049777 Ankyrins Proteins 0.000 description 1
- 102000008102 Ankyrins Human genes 0.000 description 1
- 101710081722 Antitrypsin Proteins 0.000 description 1
- 101100086302 Arabidopsis thaliana RABA1B gene Proteins 0.000 description 1
- 101000787278 Arabidopsis thaliana Valine-tRNA ligase, chloroplastic/mitochondrial 2 Proteins 0.000 description 1
- 101000787296 Arabidopsis thaliana Valine-tRNA ligase, mitochondrial 1 Proteins 0.000 description 1
- 108010008184 Aryldialkylphosphatase Proteins 0.000 description 1
- 101710148554 Astrocytic phosphoprotein PEA-15 Proteins 0.000 description 1
- 208000002814 Autosomal Recessive Polycystic Kidney Diseases 0.000 description 1
- 208000017354 Autosomal recessive polycystic kidney disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 101710111825 B-cell lymphoma 6 protein Proteins 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 108090000363 Bacterial Luciferases Proteins 0.000 description 1
- 101150007337 Bcl6 gene Proteins 0.000 description 1
- 102100026031 Beta-glucuronidase Human genes 0.000 description 1
- 102100040904 Beta-parvin Human genes 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- 108010014064 CCCTC-Binding Factor Proteins 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- 101100086436 Caenorhabditis elegans rap-1 gene Proteins 0.000 description 1
- 101100532685 Caenorhabditis elegans scc-3 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101710106619 Catenin alpha-3 Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102100036569 Cell division cycle and apoptosis regulator protein 1 Human genes 0.000 description 1
- 238000003734 CellTiter-Glo Luminescent Cell Viability Assay Methods 0.000 description 1
- ZTDFZLVUIVPZDU-QGNHJMHWSA-N Cnicin Chemical compound OC[C@H](O)C(=C)C(=O)O[C@H]1CC(/C)=C/CC\C(CO)=C\[C@H]2OC(=O)C(=C)[C@@H]21 ZTDFZLVUIVPZDU-QGNHJMHWSA-N 0.000 description 1
- 101710164904 Cold-inducible RNA-binding protein Proteins 0.000 description 1
- 101710125103 Copine-5 Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 101710181791 Cytoplasmic FMR1-interacting protein 1 Proteins 0.000 description 1
- 108091028097 Cytoplasmic polyadenylation element Proteins 0.000 description 1
- 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102100039303 DNA-directed RNA polymerase II subunit RPB2 Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 102100022692 Density-regulated protein Human genes 0.000 description 1
- 101000787280 Dictyostelium discoideum Probable valine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 108010066455 Dihydrouracil Dehydrogenase (NADP) Proteins 0.000 description 1
- 206010061819 Disease recurrence Diseases 0.000 description 1
- 108050007016 Dishevelled Proteins 0.000 description 1
- 102000017944 Dishevelled Human genes 0.000 description 1
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101710194881 ELL-associated factor 2 Proteins 0.000 description 1
- 101710116079 Ectonucleoside triphosphate diphosphohydrolase 6 Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 102100028778 Endonuclease 8-like 1 Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 101710172056 Ependymin-related protein 1 Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102100040015 Eukaryotic translation initiation factor 2 subunit 3 Human genes 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 102100029956 F-actin-capping protein subunit beta Human genes 0.000 description 1
- 108010007508 Farnesyltranstransferase Proteins 0.000 description 1
- 102000007317 Farnesyltranstransferase Human genes 0.000 description 1
- 102100039036 Feline leukemia virus subgroup C receptor-related protein 1 Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 description 1
- 108010036781 Fumarate Hydratase Proteins 0.000 description 1
- 102100036160 Fumarate hydratase, mitochondrial Human genes 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102100033837 G-protein coupled receptor 135 Human genes 0.000 description 1
- 101710104768 G-protein coupled receptor 135 Proteins 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- 108010015133 Galactose oxidase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102100031103 Geranylgeranyl transferase type-2 subunit beta Human genes 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 108050005430 Golgi membrane protein 1 Proteins 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 108091009389 Growth factor receptor-bound protein 2 Proteins 0.000 description 1
- 101100356020 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) recA gene Proteins 0.000 description 1
- 101150017137 Haspin gene Proteins 0.000 description 1
- 102100035617 Heterogeneous nuclear ribonucleoprotein A/B Human genes 0.000 description 1
- 102100027706 Heterogeneous nuclear ribonucleoprotein D-like Human genes 0.000 description 1
- 102100033994 Heterogeneous nuclear ribonucleoproteins C1/C2 Human genes 0.000 description 1
- 102000003964 Histone deacetylase Human genes 0.000 description 1
- 108090000353 Histone deacetylase Proteins 0.000 description 1
- 101710110793 Homeodomain-interacting protein kinase 2 Proteins 0.000 description 1
- 101000723517 Homo sapiens 14-3-3 protein gamma Proteins 0.000 description 1
- 101000935623 Homo sapiens 3'(2'),5'-bisphosphate nucleotidase 1 Proteins 0.000 description 1
- 101000623543 Homo sapiens 40S ribosomal protein S15 Proteins 0.000 description 1
- 101001098029 Homo sapiens 40S ribosomal protein S2 Proteins 0.000 description 1
- 101000679249 Homo sapiens 40S ribosomal protein S3a Proteins 0.000 description 1
- 101000694288 Homo sapiens 40S ribosomal protein SA Proteins 0.000 description 1
- 101000755323 Homo sapiens 60S ribosomal protein L10a Proteins 0.000 description 1
- 101000681240 Homo sapiens 60S ribosomal protein L13a Proteins 0.000 description 1
- 101000691203 Homo sapiens 60S ribosomal protein L4 Proteins 0.000 description 1
- 101000732665 Homo sapiens Acidic leucine-rich nuclear phosphoprotein 32 family member E Proteins 0.000 description 1
- 101000678845 Homo sapiens Acyl carrier protein, mitochondrial Proteins 0.000 description 1
- 101000655484 Homo sapiens Adenosine 3'-phospho 5'-phosphosulfate transporter 1 Proteins 0.000 description 1
- 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 1
- 101000613557 Homo sapiens Beta-parvin Proteins 0.000 description 1
- 101100099884 Homo sapiens CD40 gene Proteins 0.000 description 1
- 101000715197 Homo sapiens Cell division cycle and apoptosis regulator protein 1 Proteins 0.000 description 1
- 101000956872 Homo sapiens Cytoplasmic FMR1-interacting protein 1 Proteins 0.000 description 1
- 101000669831 Homo sapiens DNA-directed RNA polymerase II subunit RPB2 Proteins 0.000 description 1
- 101001044612 Homo sapiens Density-regulated protein Proteins 0.000 description 1
- 101000902632 Homo sapiens Dihydropyrimidine dehydrogenase [NADP(+)] Proteins 0.000 description 1
- 101001123824 Homo sapiens Endonuclease 8-like 1 Proteins 0.000 description 1
- 101000959829 Homo sapiens Eukaryotic translation initiation factor 2 subunit 3 Proteins 0.000 description 1
- 101000896557 Homo sapiens Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 description 1
- 101000793778 Homo sapiens F-actin-capping protein subunit beta Proteins 0.000 description 1
- 101001029786 Homo sapiens Feline leukemia virus subgroup C receptor-related protein 1 Proteins 0.000 description 1
- 101001061405 Homo sapiens Frizzled-9 Proteins 0.000 description 1
- 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 description 1
- 101001129567 Homo sapiens Geranylgeranyl transferase type-2 subunit beta Proteins 0.000 description 1
- 101001040742 Homo sapiens Golgi membrane protein 1 Proteins 0.000 description 1
- 101000854036 Homo sapiens Heterogeneous nuclear ribonucleoprotein A/B Proteins 0.000 description 1
- 101001081145 Homo sapiens Heterogeneous nuclear ribonucleoprotein D-like Proteins 0.000 description 1
- 101001017574 Homo sapiens Heterogeneous nuclear ribonucleoproteins C1/C2 Proteins 0.000 description 1
- 101001066401 Homo sapiens Homeodomain-interacting protein kinase 2 Proteins 0.000 description 1
- 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 101001008857 Homo sapiens Kelch-like protein 7 Proteins 0.000 description 1
- 101001047746 Homo sapiens Lamina-associated polypeptide 2, isoform alpha Proteins 0.000 description 1
- 101001047731 Homo sapiens Lamina-associated polypeptide 2, isoforms beta/gamma Proteins 0.000 description 1
- 101000577105 Homo sapiens Mannosyl-oligosaccharide glucosidase Proteins 0.000 description 1
- 101000731000 Homo sapiens Membrane-associated progesterone receptor component 1 Proteins 0.000 description 1
- 101000962648 Homo sapiens Mitochondrial assembly of ribosomal large subunit protein 1 Proteins 0.000 description 1
- 101000969546 Homo sapiens Mortality factor 4-like protein 1 Proteins 0.000 description 1
- 101001030625 Homo sapiens Mucin-like protein 1 Proteins 0.000 description 1
- 101000730680 Homo sapiens N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase Proteins 0.000 description 1
- 101001137535 Homo sapiens Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Proteins 0.000 description 1
- 101000912678 Homo sapiens Nucleolar RNA helicase 2 Proteins 0.000 description 1
- 101000995932 Homo sapiens Nucleolar protein 58 Proteins 0.000 description 1
- 101000720966 Homo sapiens Opsin-3 Proteins 0.000 description 1
- 101000740126 Homo sapiens Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 Proteins 0.000 description 1
- 101001067833 Homo sapiens Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 description 1
- 101001090047 Homo sapiens Peroxiredoxin-4 Proteins 0.000 description 1
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 1
- 101001105486 Homo sapiens Proteasome subunit alpha type-7 Proteins 0.000 description 1
- 101000685718 Homo sapiens Protein S100-Z Proteins 0.000 description 1
- 101000979284 Homo sapiens Protein kinase C-binding protein NELL1 Proteins 0.000 description 1
- 101001019136 Homo sapiens Putative methyltransferase-like protein 7A Proteins 0.000 description 1
- 101001132733 Homo sapiens Rab GTPase-activating protein 1 Proteins 0.000 description 1
- 101001077015 Homo sapiens Rab GTPase-activating protein 1-like Proteins 0.000 description 1
- 101001077011 Homo sapiens Rab GTPase-activating protein 1-like, isoform 10 Proteins 0.000 description 1
- 101000743845 Homo sapiens Ras-related protein Rab-10 Proteins 0.000 description 1
- 101000584595 Homo sapiens Ras-related protein Rap-1A Proteins 0.000 description 1
- 101000580351 Homo sapiens Respirasome Complex Assembly Factor 1 Proteins 0.000 description 1
- 101000650820 Homo sapiens Semaphorin-4A Proteins 0.000 description 1
- 101000621061 Homo sapiens Serum paraoxonase/arylesterase 2 Proteins 0.000 description 1
- 101000665150 Homo sapiens Small nuclear ribonucleoprotein Sm D1 Proteins 0.000 description 1
- 101000665250 Homo sapiens Small nuclear ribonucleoprotein Sm D2 Proteins 0.000 description 1
- 101000713305 Homo sapiens Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 description 1
- 101000707567 Homo sapiens Splicing factor 3B subunit 1 Proteins 0.000 description 1
- 101000615384 Homo sapiens Stromal membrane-associated protein 2 Proteins 0.000 description 1
- 101000946850 Homo sapiens T-lymphocyte activation antigen CD86 Proteins 0.000 description 1
- 101000796121 Homo sapiens Thioredoxin-like protein 1 Proteins 0.000 description 1
- 101000839330 Homo sapiens Threonine-tRNA ligase 2, cytoplasmic Proteins 0.000 description 1
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
- 101000679343 Homo sapiens Transformer-2 protein homolog beta Proteins 0.000 description 1
- 101000655141 Homo sapiens Transmembrane protein 14C Proteins 0.000 description 1
- 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 1
- 101000939529 Homo sapiens UDP-glucose 6-dehydrogenase Proteins 0.000 description 1
- 101001070756 Homo sapiens Vasculin Proteins 0.000 description 1
- 101000649171 Homo sapiens XK-related protein 6 Proteins 0.000 description 1
- 101000915623 Homo sapiens Zinc finger protein 664 Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
- 108010050586 Immunoglobulin J-Chains Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 101710135845 Inositol 1,4,5-triphosphate receptor associated 2 Proteins 0.000 description 1
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 108090001028 Iron regulatory protein 2 Proteins 0.000 description 1
- 102000004902 Iron regulatory protein 2 Human genes 0.000 description 1
- 108010031676 Kynureninase Proteins 0.000 description 1
- 101710109594 LIM domain-containing protein 1 Proteins 0.000 description 1
- 102100038609 Lactoperoxidase Human genes 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102100023981 Lamina-associated polypeptide 2, isoform alpha Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010052178 Lymphocytic lymphoma Diseases 0.000 description 1
- 108010068342 MAP Kinase Kinase 1 Proteins 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 108010054377 Mannosidases Proteins 0.000 description 1
- 102000001696 Mannosidases Human genes 0.000 description 1
- 102100025315 Mannosyl-oligosaccharide glucosidase Human genes 0.000 description 1
- 101710085938 Matrix protein Proteins 0.000 description 1
- 101710127721 Membrane protein Proteins 0.000 description 1
- 102100032399 Membrane-associated progesterone receptor component 1 Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 102100039539 Mitochondrial assembly of ribosomal large subunit protein 1 Human genes 0.000 description 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
- 108700015928 Mitogen-activated protein kinase 13 Proteins 0.000 description 1
- 102100021395 Mortality factor 4-like protein 1 Human genes 0.000 description 1
- 102100038565 Mucin-like protein 1 Human genes 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100042680 Mus musculus Slc7a1 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102100032965 Myomesin-2 Human genes 0.000 description 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 102100032979 N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase Human genes 0.000 description 1
- 101100420081 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) rps-0 gene Proteins 0.000 description 1
- 101100521838 Nicotiana tabacum pbf1 gene Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108010077641 Nogo Proteins Proteins 0.000 description 1
- 108090001145 Nuclear Receptor Coactivator 3 Proteins 0.000 description 1
- 102100021007 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 Human genes 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 102100034532 Nucleolar protein 58 Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010054076 Oncogene Proteins v-myb Proteins 0.000 description 1
- 102100037193 Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 Human genes 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
- 102000007456 Peroxiredoxin Human genes 0.000 description 1
- 102100034768 Peroxiredoxin-4 Human genes 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
- 108090000216 Phospholipid Transfer Proteins Proteins 0.000 description 1
- 102000003867 Phospholipid Transfer Proteins Human genes 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 101710170209 Platelet-derived growth factor D Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102100037427 Probable ATP-dependent RNA helicase DDX56 Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100021201 Proteasome subunit alpha type-7 Human genes 0.000 description 1
- 102100023107 Protein S100-Z Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 108010090920 Proto-Oncogene Proteins c-bcl-6 Proteins 0.000 description 1
- 102100034758 Putative methyltransferase-like protein 7A Human genes 0.000 description 1
- 101150060955 RAB11A gene Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 101710183847 Rab GTPase-activating protein 1-like Proteins 0.000 description 1
- 101710084148 Rab11 family-interacting protein 1 Proteins 0.000 description 1
- 108050002609 Ras guanyl-releasing protein 3 Proteins 0.000 description 1
- 102100039103 Ras-related protein Rab-10 Human genes 0.000 description 1
- 102100022873 Ras-related protein Rab-11A Human genes 0.000 description 1
- 102100030706 Ras-related protein Rap-1A Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 102100027558 Respirasome Complex Assembly Factor 1 Human genes 0.000 description 1
- 102100029831 Reticulon-4 Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 108091006208 SLC3 Proteins 0.000 description 1
- 102100027718 Semaphorin-4A Human genes 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 102100038685 Small nuclear ribonucleoprotein Sm D2 Human genes 0.000 description 1
- 102100036916 Sodium-coupled neutral amino acid transporter 1 Human genes 0.000 description 1
- 108010019965 Spectrin Proteins 0.000 description 1
- 102000005890 Spectrin Human genes 0.000 description 1
- 102100031711 Splicing factor 3B subunit 1 Human genes 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 102100021250 Stromal membrane-associated protein 2 Human genes 0.000 description 1
- 108010091582 Sulfate Transporters Proteins 0.000 description 1
- 102100034924 T-lymphocyte activation antigen CD86 Human genes 0.000 description 1
- 108090000920 TNF receptor-associated factor 1 Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 102100031373 Thioredoxin-like protein 1 Human genes 0.000 description 1
- 101710109859 Threonine-tRNA ligase 2, cytoplasmic Proteins 0.000 description 1
- 102100027671 Transcriptional repressor CTCF Human genes 0.000 description 1
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
- 102100022572 Transformer-2 protein homolog beta Human genes 0.000 description 1
- 101710204707 Transforming growth factor-beta receptor-associated protein 1 Proteins 0.000 description 1
- 102100033022 Transmembrane protein 14C Human genes 0.000 description 1
- 102100033598 Triosephosphate isomerase Human genes 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 206010054094 Tumour necrosis Diseases 0.000 description 1
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 1
- 108091005906 Type I transmembrane proteins Proteins 0.000 description 1
- 102100029640 UDP-glucose 6-dehydrogenase Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 108010054269 Uridine Diphosphate Glucose Dehydrogenase Proteins 0.000 description 1
- 102000057144 Uridine Diphosphate Glucose Dehydrogenase Human genes 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 102000013625 Valine-tRNA Ligase Human genes 0.000 description 1
- 102100034166 Vasculin Human genes 0.000 description 1
- 108010093528 Wiskott Aldrich Syndrome protein Proteins 0.000 description 1
- 208000006110 Wiskott-Aldrich syndrome Diseases 0.000 description 1
- 102100023034 Wiskott-Aldrich syndrome protein Human genes 0.000 description 1
- 102100027970 XK-related protein 6 Human genes 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 101710160518 Zinc finger protein 32 Proteins 0.000 description 1
- 102100028934 Zinc finger protein 664 Human genes 0.000 description 1
- 108091006550 Zinc transporters Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000009824 affinity maturation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229960000548 alemtuzumab Drugs 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229940059260 amidate Drugs 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000001475 anti-trypsic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 108700021042 biotin binding protein Proteins 0.000 description 1
- 102000043871 biotin binding protein Human genes 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 190000008236 carboplatin Chemical compound 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000011965 cell line development Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000009096 combination chemotherapy Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000004540 complement-dependent cytotoxicity Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229950009760 epratuzumab Drugs 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000003500 gene array Methods 0.000 description 1
- 238000010209 gene set analysis Methods 0.000 description 1
- 230000004547 gene signature Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
- 229960001101 ifosfamide Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000013388 immunohistochemistry analysis Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 238000000370 laser capture micro-dissection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 229950004563 lucatumumab Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 150000002671 lyxoses Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000001806 memory b lymphocyte Anatomy 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 108010029942 microperoxidase Proteins 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000004802 monitoring treatment efficacy Methods 0.000 description 1
- 210000004160 naive b lymphocyte Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 108010028584 nucleotidase Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229950005751 ocrelizumab Drugs 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229940043515 other immunoglobulins in atc Drugs 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229950007318 ozogamicin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 108010082406 peptide permease Proteins 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 108030002458 peroxiredoxin Proteins 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 238000009521 phase II clinical trial Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108010055438 prepronociceptin Proteins 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 108700039148 rab11 Proteins 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000001350 reed-sternberg cell Anatomy 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 108010033674 rho GTP-Binding Proteins Proteins 0.000 description 1
- 102000007268 rho GTP-Binding Proteins Human genes 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- HNMATTJJEPZZMM-BPKVFSPJSA-N s-[(2r,3s,4s,6s)-6-[[(2r,3s,4s,5r,6r)-5-[(2s,4s,5s)-5-[acetyl(ethyl)amino]-4-methoxyoxan-2-yl]oxy-6-[[(2s,5z,9r,13e)-13-[2-[[4-[(2e)-2-[1-[4-(4-amino-4-oxobutoxy)phenyl]ethylidene]hydrazinyl]-2-methyl-4-oxobutan-2-yl]disulfanyl]ethylidene]-9-hydroxy-12-(m Chemical compound C1[C@H](OC)[C@@H](N(CC)C(C)=O)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@@](C/3=C/CSSC(C)(C)CC(=O)N\N=C(/C)C=3C=CC(OCCCC(N)=O)=CC=3)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HNMATTJJEPZZMM-BPKVFSPJSA-N 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003341 sedoheptuloses Chemical class 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229960005267 tositumomab Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000440 toxicity profile Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
- 150000003742 xyloses Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98627707P | 2007-11-07 | 2007-11-07 | |
| US60/986,277 | 2007-11-07 | ||
| PCT/US2008/082920 WO2009062125A1 (en) | 2007-11-07 | 2008-11-07 | Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2704499A1 CA2704499A1 (en) | 2009-05-14 |
| CA2704499C true CA2704499C (en) | 2020-03-10 |
Family
ID=40377361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2704499A Active CA2704499C (en) | 2007-11-07 | 2008-11-07 | Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9068230B2 (enExample) |
| EP (1) | EP2222875B1 (enExample) |
| JP (2) | JP5730576B2 (enExample) |
| KR (1) | KR101620642B1 (enExample) |
| CN (1) | CN101910414B (enExample) |
| AU (1) | AU2008323701B2 (enExample) |
| BR (1) | BRPI0820707A2 (enExample) |
| CA (1) | CA2704499C (enExample) |
| IL (1) | IL205391A (enExample) |
| MX (1) | MX2010005080A (enExample) |
| WO (1) | WO2009062125A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9075066B2 (en) * | 2008-04-21 | 2015-07-07 | Korea Research Institute Of Bioscience And Biotechnology | CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer |
| US9528160B2 (en) | 2008-11-07 | 2016-12-27 | Adaptive Biotechnolgies Corp. | Rare clonotypes and uses thereof |
| US8628927B2 (en) | 2008-11-07 | 2014-01-14 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| GB2483810B (en) | 2008-11-07 | 2012-09-05 | Sequenta Inc | Methods for correlating clonotypes with diseases in a population |
| US9365901B2 (en) | 2008-11-07 | 2016-06-14 | Adaptive Biotechnologies Corp. | Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia |
| US8748103B2 (en) | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
| PT2387627E (pt) | 2009-01-15 | 2016-06-03 | Adaptive Biotechnologies Corp | Determinação do perfil de imunidade adaptativa e métodos de geração de anticorpos monoclonais |
| US9617600B2 (en) | 2009-04-18 | 2017-04-11 | Genentech, Inc. | Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies |
| JP2012531202A (ja) | 2009-06-25 | 2012-12-10 | フレッド ハチンソン キャンサー リサーチ センター | 適応免疫を測定する方法 |
| US20130095473A1 (en) * | 2010-06-14 | 2013-04-18 | Qiagen Gmbh | Method for determination of target cells or tissue for extraction of biomolecules from fixed biological samples |
| CN103502472B (zh) | 2011-02-28 | 2017-06-06 | 弗·哈夫曼-拉罗切有限公司 | 生物标记物和用于预测对b‑细胞拮抗剂的响应的方法 |
| US8592156B2 (en) * | 2011-08-08 | 2013-11-26 | Roche Molecular Systems, Inc. | Predicting response to anti-CD20 therapy in DLBCL patients |
| WO2013036459A2 (en) * | 2011-09-09 | 2013-03-14 | Sequenta, Inc. | Sequence-based measures of immune response |
| US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
| EP2768982A4 (en) | 2011-10-21 | 2015-06-03 | Adaptive Biotechnologies Corp | QUANTIFICATION OF ADAPTIVE IMMUNOCELL GENOMES IN A COMPLEX MIX OF CELLS |
| AU2012347460B2 (en) | 2011-12-09 | 2017-05-25 | Adaptive Biotechnologies Corporation | Diagnosis of lymphoid malignancies and minimal residual disease detection |
| US9499865B2 (en) | 2011-12-13 | 2016-11-22 | Adaptive Biotechnologies Corp. | Detection and measurement of tissue-infiltrating lymphocytes |
| JP6302847B2 (ja) | 2012-03-05 | 2018-03-28 | アダプティヴ バイオテクノロジーズ コーポレーション | 頻度が一致したサブユニットからの、対をなす免疫受容体鎖の決定 |
| ES2711156T3 (es) | 2012-05-08 | 2019-04-30 | Adaptive Biotechnologies Corp | Método para medir y calibrar el sesgo de amplificación en reacciones de PCR multiplexadas |
| EP2904111B1 (en) | 2012-10-01 | 2017-12-06 | Adaptive Biotechnologies Corporation | Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization |
| US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
| ES2923942T3 (es) * | 2013-11-06 | 2022-10-03 | Us Health | Procedimiento para el subtipado de tipos de linfoma por medio de perfiles de expresión |
| US20170292149A1 (en) | 2014-03-05 | 2017-10-12 | Adaptive Biotechnologies Corporation | Methods using randomer-containing synthetic molecules |
| MA39804A (fr) * | 2014-03-27 | 2017-02-01 | Hoffmann La Roche | Méthodes permettant le diagnostic et le traitement d'une maladie inflammatoire de l'intestin |
| US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
| ES2777529T3 (es) | 2014-04-17 | 2020-08-05 | Adaptive Biotechnologies Corp | Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células |
| WO2016069886A1 (en) | 2014-10-29 | 2016-05-06 | Adaptive Biotechnologies Corporation | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
| AU2015339128C1 (en) | 2014-10-29 | 2021-12-16 | Seagen Inc. | Dosage and administration of non-fucosylated anti-CD40 antibodies |
| US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
| CA2968543C (en) | 2014-11-25 | 2024-04-02 | Adaptive Biotechnologies Corporation | Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing |
| WO2016138122A1 (en) | 2015-02-24 | 2016-09-01 | Adaptive Biotechnologies Corp. | Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing |
| WO2016161273A1 (en) | 2015-04-01 | 2016-10-06 | Adaptive Biotechnologies Corp. | Method of identifying human compatible t cell receptors specific for an antigenic target |
| EP3329244B1 (en) | 2015-07-30 | 2022-10-05 | Qiagen GmbH | Method of preparing a frozen biological sample |
| ES2885476T3 (es) * | 2015-10-05 | 2021-12-13 | Ucb Biopharma Sprl | Firmas moleculares para uso en diagnóstico y análisis de respuesta al tratamiento de enfermedades autoinmunes |
| CN109414451B (zh) * | 2016-05-16 | 2022-08-12 | 德克萨斯大学系统董事会 | 用于作为纳米粒递送tRNA的组合物及其使用方法 |
| BR112018076260A2 (pt) | 2016-06-20 | 2019-03-26 | Kymab Limited | anticorpo ou fragmento do mesmo que se liga especificamente a hpd-l1, anticorpo biespecífico ou proteína de fusão, uso de um anticorpo ou fragmento, método, composição farmacêutica, método de modulação, método de inibição, método de tratamento, ácido nucleico, vetor, hospedeiro e imunocitocina |
| US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
| CA3053358A1 (en) | 2017-04-04 | 2018-10-11 | F. Hoffmann-La Roche Ag | Novel bispecific antigen binding molecules capable of specific binding to cd40 and to fap |
| US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
| WO2022120038A1 (en) * | 2020-12-02 | 2022-06-09 | Albert Einstein College Of Medicine | Method for predicting patient response to cd40-targeted therapies |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
| US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US5182368A (en) | 1986-06-13 | 1993-01-26 | Ledbetter Jeffrey A | Ligands and methods for augmenting B-cell proliferation |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US5874082A (en) | 1992-07-09 | 1999-02-23 | Chiron Corporation | Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation |
| DE69433820T2 (de) | 1993-12-23 | 2005-06-23 | Immunex Corp., Seattle | Verwendung von löslichen oligomerischen cd40 liganden oder monoklonalen antikörpern zur herstellung eines arzneimitells zur vorbeugung oder behandlung von neoplastischen krankheiten |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| GB9425060D0 (en) | 1994-12-13 | 1995-02-08 | Univ Birmingham | Carcinoma treatment |
| JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク． | 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体 |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| DE19544393A1 (de) | 1995-11-15 | 1997-05-22 | Hoechst Schering Agrevo Gmbh | Synergistische herbizide Mischungen |
| DE69738539T2 (de) | 1996-12-03 | 2009-03-26 | Amgen Fremont Inc. | Vollkommen humane Antikörper die EGFR binden |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| US6248535B1 (en) | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| IL151865A0 (en) | 2000-03-31 | 2003-04-10 | Genentech Inc | Compositions and methods for detecting and quantifying gene expression |
| WO2001083755A2 (en) | 2000-04-28 | 2001-11-08 | La Jolla Institute For Allergy And Immunology | Human anti-cd40 antibodies and methods of making and using same |
| WO2002078766A2 (en) | 2001-04-02 | 2002-10-10 | Genentech, Inc. | Combination therapy |
| JP4025881B2 (ja) | 2001-04-27 | 2007-12-26 | キリンファーマ株式会社 | 抗ｃｄ４０モノクローナル抗体 |
| AR039067A1 (es) | 2001-11-09 | 2005-02-09 | Pfizer Prod Inc | Anticuerpos para cd40 |
| WO2004071572A2 (en) * | 2003-02-06 | 2004-08-26 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| US7767387B2 (en) * | 2003-06-13 | 2010-08-03 | Sagres Discovery, Inc. | Therapeutic targets in cancer |
| US7711492B2 (en) * | 2003-09-03 | 2010-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for diagnosing lymphoma types |
| SI1682177T1 (sl) | 2003-11-04 | 2010-12-31 | Novartis Vaccines & Diagnostic | Uporaba antagonističnih anti-CD40 protiteles za zdravljenje kronične limfocitne levkemije |
| RS53073B (sr) | 2003-11-04 | 2014-04-30 | Novartis Vaccines And Diagnostics Inc. | Upotreba antagonističkih anti-cd40 monoklonska antitela |
| CA2848463A1 (en) | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| WO2006044294A2 (en) | 2004-10-14 | 2006-04-27 | Eli Lilly And Company | Human protein c analogs |
| JP5421590B2 (ja) * | 2005-05-18 | 2014-02-19 | ノバルティス アーゲー | 自己免疫および／または炎症性成分を有する疾患の診断および治療のための方法 |
| WO2006125143A2 (en) * | 2005-05-18 | 2006-11-23 | Novartis Ag | Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| ATE485057T1 (de) | 2005-05-26 | 2010-11-15 | Seattle Genetics Inc | Humanisierte antikörper gegen cd40 und verfahren zu ihrer anwendung |
| JP5904569B2 (ja) | 2005-06-08 | 2016-04-13 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 癌治療を受けている患者の同定、判定および処置のための方法 |
| JP2009508484A (ja) | 2005-09-16 | 2009-03-05 | バイオベイター・テクノロジーズ・アクチボラゲット | アレルゲン性タンパク質の同定のためのインビトロアッセイ |
| DE102005052384B4 (de) | 2005-10-31 | 2009-09-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Erkennung, Markierung und Behandlung von epithelialen Lungentumorzellen sowie Mittel zur Durchführung des Verfahrens |
| US7527774B2 (en) | 2005-12-22 | 2009-05-05 | Basf Catalysts Llc | Inlet metallic foam support coupled to precious metal catalyst for application on 4 stroke platforms |
| EP1987161A4 (en) | 2006-01-20 | 2009-06-24 | Univ Mcgill | METHOD FOR IDENTIFYING CD40-SENSITIVE CELLS |
| RU2473555C2 (ru) * | 2006-12-19 | 2013-01-27 | ДжинГоу, Инк. | Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных |
| US9617600B2 (en) | 2009-04-18 | 2017-04-11 | Genentech, Inc. | Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies |
-
2008
- 2008-11-07 BR BRPI0820707-0A patent/BRPI0820707A2/pt not_active Application Discontinuation
- 2008-11-07 CA CA2704499A patent/CA2704499C/en active Active
- 2008-11-07 WO PCT/US2008/082920 patent/WO2009062125A1/en not_active Ceased
- 2008-11-07 KR KR1020107012374A patent/KR101620642B1/ko active Active
- 2008-11-07 JP JP2010533308A patent/JP5730576B2/ja active Active
- 2008-11-07 US US12/741,814 patent/US9068230B2/en active Active
- 2008-11-07 CN CN200880124201.5A patent/CN101910414B/zh active Active
- 2008-11-07 EP EP08848388.8A patent/EP2222875B1/en active Active
- 2008-11-07 AU AU2008323701A patent/AU2008323701B2/en active Active
- 2008-11-07 MX MX2010005080A patent/MX2010005080A/es active IP Right Grant
-
2010
- 2010-04-28 IL IL205391A patent/IL205391A/en active IP Right Grant
-
2013
- 2013-10-09 JP JP2013211645A patent/JP2014057588A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN101910414A (zh) | 2010-12-08 |
| US20110104671A1 (en) | 2011-05-05 |
| JP5730576B2 (ja) | 2015-06-10 |
| EP2222875A1 (en) | 2010-09-01 |
| BRPI0820707A2 (pt) | 2015-06-16 |
| KR101620642B1 (ko) | 2016-05-12 |
| AU2008323701B2 (en) | 2015-03-26 |
| CN101910414B (zh) | 2016-01-13 |
| KR20100095564A (ko) | 2010-08-31 |
| MX2010005080A (es) | 2010-07-28 |
| US9068230B2 (en) | 2015-06-30 |
| JP2014057588A (ja) | 2014-04-03 |
| JP2011504102A (ja) | 2011-02-03 |
| IL205391A (en) | 2015-08-31 |
| EP2222875B1 (en) | 2014-08-20 |
| WO2009062125A1 (en) | 2009-05-14 |
| IL205391A0 (en) | 2010-12-30 |
| AU2008323701A1 (en) | 2009-05-14 |
| CA2704499A1 (en) | 2009-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2704499C (en) | Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies | |
| CN101473045B (zh) | 用于检测自身免疫性病症的方法和组合物 | |
| AU2010236168B2 (en) | Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies | |
| US20080318800A1 (en) | Methods and compositions for detecting autoimmune disorders | |
| AU2013202908A1 (en) | Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies | |
| AU2013203418A1 (en) | Methods and compositions for detecting autoimmune disorders | |
| HK1231131A1 (en) | Methods and compositions for detecting autoimmune disorders | |
| HK1158700B (en) | Methods and compositions for detecting autoimmune disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20131107 |